Dainippon Sumitomo Pharma Shares Up Despite Big Drop In Tokyo Stock Market
This article was originally published in PharmAsia News
Dainippon Sumitomo Pharma Co. is among five stocks whose share prices went up despite a ¥616 drop in the Nikkei 225 Index. It is one indication that the market has absorbed the downward correction of DSP's business performance ending in March 2007 and expected the share to bounce back
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.